MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblasts

References

• Dang CV. MYC on the path to cancer. Cell. 2012;149:22–35.
   PubMed Web of Science ®Google Scholar
• Kress TR, Sabo A, Amati B. MYC: connecting selective transcriptional control to global RNA production. Nat Rev Cancer. 2015;15:593–607.
   PubMed Web of Science ®Google Scholar
• Larsson LG, Henriksson MA. The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapy. Exp Cell Res. 2010;316:1429–1437.
   PubMed Web of Science ®Google Scholar
• Simanshu DK, Nissley DV, McCormick F. RAS Proteins and Their Regulators in Human Disease. Cell. 2017;170:17–33.
   PubMed Web of Science ®Google Scholar
• Serrano M, Lin AW, McCurrach ME, et al. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997;88:593–602.
   PubMed Web of Science ®Google Scholar
• Campisi J, d’Adda Di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007;8:729–740.
   PubMed Web of Science ®Google Scholar
• Kuilman T, Michaloglou C, Mooi WJ, et al. The essence of senescence. Genes Dev. 2010;24:2463–2479.
   PubMed Web of Science ®Google Scholar
• Munoz-Espin D, Serrano M. Cellular senescence: from physiology to pathology. Nat Rev Mol Cell Biol. 2014;15:482–496.
   PubMed Web of Science ®Google Scholar
• Bartek J, Lukas J. DNA damage checkpoints: from initiation to recovery or adaptation. Curr Opin Cell Biol. 2007;19:238–245.
   PubMed Web of Science ®Google Scholar
• Vousden KH, Lane DP. p53 in health and disease. Nature reviews. Mol Cell Biol. 2007;8:275–283.
   Google Scholar
• Hydbring P, Malumbres M, Sicinski P. Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases. Nat Rev Mol Cell Biol. 2016;17:280–292.
   PubMed Web of Science ®Google Scholar
• Evan GI, Wyllie AH, Gilbert CS, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 1992;69:119–128.
   PubMed Web of Science ®Google Scholar
• Hydbring P, Bahram F, Su Y, et al. Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation. Proc Natl Acad Sci U S A. 2010;107:58–63.
   PubMed Web of Science ®Google Scholar
• Land H, Parada LF, Weinberg RA. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature. 1983;304:596–602.
   PubMed Web of Science ®Google Scholar
• Juan J, Muraguchi T, Iezza G, et al. Diminished WNT ->; beta-catenin ->; c-MYC signaling is a barrier for malignant progression of BRAFV600E-induced lung tumors. Genes Dev. 2014;28:561–575.
   PubMed Web of Science ®Google Scholar
• Kortlever RM, Sodir NM, Wilson CH, et al. Myc Cooperates with Ras by Programming Inflammation and Immune Suppression. Cell. 2017;171:1301–1315 e1314.
   PubMed Web of Science ®Google Scholar
• Podsypanina K, Politi K, Beverly LJ, et al. Oncogene cooperation in tumor maintenance and tumor recurrence in mouse mammary tumors induced by Myc and mutant Kras. Proc Natl Acad Sci U S A. 2008;105:5242–5247.
   PubMed Web of Science ®Google Scholar
• Sinn E, Muller W, Pattengale P, et al. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell. 1987;49:465–475.
   PubMed Web of Science ®Google Scholar
• Soucek L, Whitfield J, Martins CP, et al. Modelling Myc inhibition as a cancer therapy. Nature. 2008;455:679–683.
   PubMed Web of Science ®Google Scholar
• Tabor V, Bocci M, Alikhani N, et al. MYC synergizes with activated BRAFV600E in mouse lung tumor development by suppressing senescence. Cancer Res. 2014;74:4222–4229.
   PubMed Web of Science ®Google Scholar
• Thompson TC, Southgate J, Kitchener G, et al. Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell. 1989;56:917–930.
   PubMed Web of Science ®Google Scholar
• Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature. 1997;385:544–548.
   PubMed Web of Science ®Google Scholar
• Tsuneoka M, Mekada E. Ras/MEK signaling suppresses Myc-dependent apoptosis in cells transformed by c-myc and activated ras. Oncogene. 2000;19:115–123.
   PubMed Web of Science ®Google Scholar
• Stevenson M, Volsky DJ. Activated v-myc and v-ras oncogenes do not transform normal human lymphocytes. Mol Cell Biol. 1986;6:3410–3417.
   PubMed Web of Science ®Google Scholar
• Boehm JS, Hession MT, Bulmer SE, et al. Transformation of human and murine fibroblasts without viral oncoproteins. Mol Cell Biol. 2005;25:6464–6474.
   PubMed Web of Science ®Google Scholar
• Drayton S, Rowe J, Jones R, et al. Tumor suppressor p16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes. Cancer Cell. 2003;4:301–310.
   PubMed Web of Science ®Google Scholar
• Hahn WC, Counter CM, Lundberg AS, et al. Creation of human tumour cells with defined genetic elements. Nature. 1999;400:464–468.
   PubMed Web of Science ®Google Scholar
• Hahn WC, Dessain SK, Brooks MW, et al. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol. 2002;22:2111–2123.
   PubMed Web of Science ®Google Scholar
• Kendall SD, Linardic CM, Adam SJ, et al. A network of genetic events sufficient to convert normal human cells to a tumorigenic state. Cancer Res. 2005;65:9824–9828.
   PubMed Web of Science ®Google Scholar
• Morales CP, Holt SE, Ouellette M, et al. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet. 1999;21:115–118.
   PubMed Web of Science ®Google Scholar
• Rangarajan A, Hong SJ, Gifford A, et al. Species- and cell type-specific requirements for cellular transformation. Cancer Cell. 2004;6:171–183.
   PubMed Web of Science ®Google Scholar
• Seger YR, Garcia-Cao M, Piccinin S, et al. Transformation of normal human cells in the absence of telomerase activation. Cancer Cell. 2002;2:401–413.
   PubMed Web of Science ®Google Scholar
• Voorhoeve PM, Agami R. The tumor-suppressive functions of the human INK4A locus. Cancer Cell. 2003;4:311–319.
   PubMed Web of Science ®Google Scholar
• Yeh E, Cunningham M, Arnold H, et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol. 2004;6:308–318.
   PubMed Web of Science ®Google Scholar
• Evangelou K, Bartkova J, Kotsinas A, et al. The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis. Cell Death Differ. 2013;20:1485–1497.
   PubMed Web of Science ®Google Scholar
• Maya-Mendoza A, Ostrakova J, Kosar M, et al. Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress. Mol Oncol. 2015;9:601–616.
   PubMed Web of Science ®Google Scholar
• Littlewood TD, Hancock DC, Danielian PS, et al. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 1995;23:1686–1690.
   PubMed Web of Science ®Google Scholar
• Bahram F, Hydbring P, Tronnersjo S, et al. Interferon-gamma-induced p27KIP1 binds to and targets MYC for proteasome-mediated degradation. Oncotarget. 2016;7:2837–2854.
   PubMedGoogle Scholar
• Benassi B, Fanciulli M, Fiorentino F, et al. c-Myc phosphorylation is required for cellular response to oxidative stress. Mol Cell. 2006;21:509–519.
   PubMed Web of Science ®Google Scholar
• Farrell AS, Sears RC. MYC degradation. Cold Spring Harb Perspect Med. 2014;4:a014365-a014365.
   PubMed Web of Science ®Google Scholar
• Hydbring P, Castell A, Larsson LG. MYC Modulation around the CDK2/p27/SKP2 Axis. Genes (Basel). 2017;8:174.
   PubMed Web of Science ®Google Scholar
• Myant K, Qiao X, Halonen T, et al. Serine 62-Phosphorylated MYC Associates with Nuclear Lamins and Its Regulation by CIP2A Is Essential for Regenerative Proliferation. Cell Rep. 2015;12:1019–1031.
   PubMed Web of Science ®Google Scholar
• Sears R, Nuckolls F, Haura E, et al. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 2000;14:2501–2514.
   PubMed Web of Science ®Google Scholar
• Grignani F, Lombardi L, Inghirami G, et al. Negative autoregulation of c-myc gene expression is inactivated in transformed cells. Embo J. 1990;9:3913–3922.
   PubMed Web of Science ®Google Scholar
• Penn LJ, Brooks MW, Laufer EM, et al. Negative autoregulation of c-myc transcription. Embo J. 1990;9:1113–1121.
   PubMed Web of Science ®Google Scholar
• Vafa O, Wade M, Kern S, et al. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell. 2002;9:1031–1044.
   PubMed Web of Science ®Google Scholar
• Beausejour CM, Krtolica A, Galimi F, et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways. Embo J. 2003;22:4212–4222.
   PubMed Web of Science ®Google Scholar
• Lowe SW, Ruley HE. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 1993;7:535–545.
   PubMed Web of Science ®Google Scholar
• Huot TJ, Rowe J, Harland M, et al. Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts. Mol Cell Biol. 2002;22:8135–8143.
   PubMed Web of Science ®Google Scholar
• Lin AW, Barradas M, Stone JC, et al. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 1998;12:3008–3019.
   PubMed Web of Science ®Google Scholar
• Benanti JA, Galloway DA. Normal human fibroblasts are resistant to RAS-induced senescence. Mol Cell Biol. 2004;24:2842–2852.
   PubMed Web of Science ®Google Scholar
• Zhuang D, Mannava S, Grachtchouk V, et al. C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells. Oncogene. 2008;27:6623–6634.
   PubMed Web of Science ®Google Scholar
• Campaner S, Doni M, Hydbring P, et al. Cdk2 suppresses cellular senescence induced by the c-myc oncogene. Nat Cell Biol. 2010;12:54–59; sup 51-14
   PubMed Web of Science ®Google Scholar
• Dominguez-Sola D, Ying CY, Grandori C, et al. Non-transcriptional control of DNA replication by c-Myc. Nature. 2007;448:445–451.
   PubMed Web of Science ®Google Scholar
• Duncan JS, Whittle MC, Nakamura K, et al. Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer. Cell. 2012;149:307–321.
   PubMed Web of Science ®Google Scholar
• Kerkhoff E, Houben R, Loffler S, et al. Regulation of c-myc expression by Ras/Raf signalling. Oncogene. 1998;16:211–216.
   PubMed Web of Science ®Google Scholar
• Cannell IG, Kong YW, Johnston SJ, et al. p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication. Proc Natl Acad Sci U S A. 2010;107:5375–5380.
   PubMed Web of Science ®Google Scholar
• Sakamuro D, Eviner V, Elliott KJ, et al. c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene. 1995;11:2411–2418.
   PubMed Web of Science ®Google Scholar
• Hogstrand K, Hejll E, Sander B, et al. Inhibition of the intrinsic but not the extrinsic apoptosis pathway accelerates and drives MYC-driven tumorigenesis towards acute myeloid leukemia. PLoS One. 2012;7:e31366.
   PubMed Web of Science ®Google Scholar
• Nyakeriga AM, Djerbi M, Malinowski MM, et al. Simultaneous expression and detection of multiple retroviral constructs in haematopoietic cells after bone marrow transplantation. Scand J Immunol. 2005;61:545–550.
   PubMed Web of Science ®Google Scholar
• Itahana K, Itahana Y, Dimri GP. Colorimetric detection of senescence-associated beta galactosidase. Methods Mol Biol. 2013;965:143–156.
   PubMedGoogle Scholar